Concepedia
Statistics
Publications
18
Citations
941
H-Index
15
Active since
1982
Affiliations
GlaxoSmithKline (United Kingdom)(Current)
University of Florida
Florida College
Research Triangle Park Foundation
Florey Institute of Neuroscience and Mental Health
Kathryn J. Smith is an author at GlaxoSmithKline (United Kingdom) specializing in pharmacology, pharmacy, and drug discovery.
Publications per year
1982–2021
The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancer.
David W. Rusnak, Karen Affleck, Stuart Cockerill et al. · PubMed · 2001 · 297 citations
Medicine, Oncology, Pharmacology +15
Urotensin II Acts Centrally to Increase Epinephrine and ACTH Release and Cause Potent Inotropic and Chronotropic Actions
Anna M.D. Watson, Gavin Lambert, Kathryn J. Smith et al. · Hypertension · 2003 · 88 citations
Life Sciences, Pharmacology, Physiology +14
Indazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and c-erbB-2
Stuart Cockerill, Colin Stubberfield, Jeremy N. Stables et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 80 citations · Full text
Medicine, Medicinal Chemistry, Oncology +9
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity
Richard Angell, Paul Bamborough, Jacky B. Buckton et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 78 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +9
Discovery and Biological Evaluation of Potent Dual ErbB-2/EGFR Tyrosine Kinase Inhibitors: 6-Thiazolylquinazolines
Micheal D. Gaul, Yu Guo, Karen Affleck et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 59 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +12
1–5 of 18